Authored By: Sarah
10 Dec 2024

Latest News - HIV Rapid Test Kits Market 2024-2028: North America Leads Market Growth and Key Industry Insights

Human Immunodeficiency Virus (HIV) Rapid Test Kits Market to grow at a CAGR of 6.52% during 2024-2028

The Human Immunodeficiency Virus (HIV) Rapid Test Kits Market is expected to grow at a CAGR of 6.52% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 294.96 million. In the global fight against HIV, pre-marital screening has emerged as a crucial initiative to prevent the transmission of this infectious disease. Governments worldwide have recognized the importance of this health assessment for soon-to-be-married couples, which identifies the presence of HIV and other sexually transmitted diseases (STDs) and infectious, genetic diseases. By implementing such programs, at-risk couples can take necessary precautions to protect themselves and their future offspring from HIV infection. The implementation of pre-marital screening tests has witnessed significant growth in developed countries, such as the US, and emerging economies, including the UAE. This trend is expected to continue as awareness about the benefits of pre-marital screening increases. 

Get more information on Human Immunodeficiency Virus (HIV) Rapid Test Kits Market by requesting a sample report

The Diagnostic centers subsegment is expected to dominate the End-user segment during the forecast period 

Technavio analysts predict that the Diagnostic centers subsegment will lead the End-user segment during 2024 and 2028 In the expanding healthcare sector, diagnostic services have witnessed significant growth due to the increasing recognition of the importance of early disease detection. One such disease is Human Immunodeficiency Virus (HIV), for which timely diagnosis is crucial. The HIV rapid test kits market is experiencing robust growth, driven by factors such as heightened public awareness regarding HIV testing, the convenience and speed of these tests, and the expanding range of healthcare facilities offering HIV testing services. Notable HIV rapid tests include Abbott's Determine HIV-1/2 Ag/Ab Combo assay, a fourth-generation point-of-care (POC) test that detects both HIV-1/2 antibodies and free HIV-1 p24 antigen on a single test strip; Trinity Biotech Plc's Uni-Gold Recombigen HIV-1/2 rapid immunoassay, which identifies antibodies to HIV-1 and/or HIV-2 in serum, plasma, and whole blood; and bioLytical Laboratories Inc.'s INSTI HIV-1/HIV-2 Rapid Antibody Test, which offers rapid and accurate results for HIV-1 and HIV-2 antibodies. These tests are instrumental in ensuring timely and accurate HIV diagnoses, contributing significantly to the market's expansion.

Here are the various ways based on which the market is segmented: 

  • End-user
    • Diagnostic centers
    • Hospitals
    • clinics
  • Type
    • HIV rapid immunoassay test
    • HIV rapid molecular diagnostic test
  • Geography
    • North America
      • US
      • Canada
    • Europe
      • Germany
      • UK
      • France
      • Russia
      • Italy
      • Spain
      • Rest of Europe
    • South America
      • Argentina
      • Brazil
      • Rest of South America
    • Middle East and Africa
      • GCC Countries
      • South Africa
      • Rest of Middle East and Africa
    • APAC
      • China
      • India
      • Japan
      • Malaysia
      • Thailand
      • Indonesia
      • Rest of APAC

Key Companies and Market Insights
Some of the key companies in the Human Immunodeficiency Virus HIV Rapid Test Kits Market include:

  • Atomo Diagnostics
  • SD Biosensor
  • CTK Biotech
  • Genedrive Plc
  • Hyrex Diagnostics
  • Trinity Biotech
  • Mylan Laboratories
  • BioSure
  • PerkinElmer
  • Acon Laboratories
  • OraSure Technologies
  • Abbott Laboratories
  • Roche Diagnostics
  • Siemens Healthineers
  • MP Biomedicals  
  • Sedia Biosciences Corp.
  • Chembio Diagnostic Systems Inc.
  • OraSure Technologies Inc.
  • Biosynex Group
  • Bedford Biotech Nigeria

Reasons to Purchase the Global Human Immunodeficiency Virus (HIV) Rapid Test Kits Market Market Research Report by Technavio. What is in it for you?

  • Wealth of Experience: Technavio is an established name in the world of market research. It holds an expertise of more than 20 years in the field, has published 21,000+ reports thereby extensively covering the area in various industries and range of regions
  • Insight into Current Market Trends: Our research reports provide our readers insights into the latest market intelligence, competitor strategies, market trends, changes taking place in the industry and customer preferences, forecasted market opportunities that influence them to make better business decisions
  • High ROI with Extensive Hands-on Research: Technavio is renowned for offering personalized market research reports as per unique business needs, delving deep into specific markets, product segments and demographics. Additionally, it is also well-known for providing high return on investments through its wide collection of data at pocket-friendly rates

There are several factors that are causing the market to flourish rise in awareness programs for hiv testing

Learn which are the obstacles that the market is experiencing in the way of its growth by accessing the free PDF report

Research Analysis Overview

The Human Immunodeficiency Virus (HIV) Rapid Test Kits market has witnessed significant growth in recent years due to the increasing awareness of HIV infection and the need for early detection and prevention. HIV testing kits have become an essential tool for both healthcare providers and individuals, with applications ranging from hospital settings to home use. HIV Rapid Test Kits are available in various formats, including blood samples and oral fluid testing using saliva samples. Home use HIV self-testing kits have gained popularity due to their convenience and privacy, allowing individuals to test themselves in the comfort of their own homes. Digital tools and advanced technologies have enhanced the precision and versatility of HIV testing kits, making them more reliable and accessible. Awareness campaigns and public health programs have played a crucial role in increasing the adoption of HIV testing, particularly in resource-limited settings. Healthcare infrastructure and the role of healthcare professionals have been instrumental in ensuring the accurate and timely diagnosis of HIV infection. The use of HIV testing kits in blood transfusions has also reduced the risk of HIV transmission through blood transfusions significantly. In conclusion, the HIV Rapid Test Kits market is poised for continued growth, driven by the need for early detection, prevention, and the increasing adoption of home use testing. The market is expected to witness significant innovation and advancements in the coming years, making HIV testing more accessible, convenient, and reliable for individuals and healthcare providers alike.

Market Research Overview

The Human Immunodeficiency Virus (HIV) Rapid Test Kits market is a significant segment of the global Life Sciences Tools and Services industry, according to Technavio. This market is included in the broader category of the Life Sciences Tools and Services market, which encompasses businesses and products involved in the research and development (R&D) of various product categories, such as capital equipment, instruments, accessories, and consumables. These tools and services are utilized for R&D on pharmaceuticals and biotechnology products, as well as laboratory diagnosis of various diseases. Additionally, the market covers life sciences-related services, including contract research, contract manufacturing, and contract sales. Technavio's market analysis calculates the size of the Life Sciences Tools and Services market based on the consolidated revenue generated by manufacturers of equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services.

The Human Immunodeficiency Virus (HIV) Rapid Test Kits Market is experiencing significant growth, fueled by the rise in awareness programs for hiv testing. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

 

Read News Read Less
Interested in this report?
Get your sample now!

Safe and Secure SSL Encrypted

Technavio

  • 2500 USD

[5 reports/month/user]

  • 5000 USD

close
  • Basic Plan [5000 USD/Year]:

    Single User
    Download 5 Reports/Month
    View 100 Reports/Month
    Add upto 3 Users at 625 USD/user

  • Teams Plan [7500 USD/Year]:

    5 User
    Download 5 Reports/Month/User
    View 100 Reports/Month/User
    Add upto 30 Users at 500 USD/user

*You can upgrade to Teams plan at Subscription page

close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization).
    Complimentary Customization Included

*For Enterprise license, go to checkout page

Technavio Get the report (PDF) sent to your email within minutes.